{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T19:55:31Z","timestamp":1770753331531,"version":"3.50.0"},"reference-count":42,"publisher":"Microbiology Society","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,9,1]]},"DOI":"10.1099\/vir.0.000197","type":"journal-article","created":{"date-parts":[[2015,5,28]],"date-time":"2015-05-28T00:21:14Z","timestamp":1432772474000},"page":"2614-2622","source":"Crossref","is-referenced-by-count":8,"title":["Brunenders: a partially attenuated historic poliovirus type I vaccine strain"],"prefix":"10.1099","volume":"96","author":[{"given":"Barbara P.","family":"Sanders","sequence":"first","affiliation":[{"name":"Janssen Infectious Diseases and Vaccines, Leiden, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Molecular Genetics and Microbiology, Stony Brook University, Stony Brook, NY 11794-5222, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alies","family":"Brandjes","sequence":"additional","affiliation":[{"name":"Janssen Infectious Diseases and Vaccines, Leiden, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vladimir","family":"van Hoek","sequence":"additional","affiliation":[{"name":"Janssen Infectious Diseases and Vaccines, Leiden, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabel","family":"de los Rios Oakes","sequence":"additional","affiliation":[{"name":"Janssen Infectious Diseases and Vaccines, Leiden, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Lewis","sequence":"additional","affiliation":[{"name":"Janssen Infectious Diseases and Vaccines, Leiden, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eckard","family":"Wimmer","sequence":"additional","affiliation":[{"name":"Department of Molecular Genetics and Microbiology, Stony Brook University, Stony Brook, NY 11794-5222, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jerome H. H. V.","family":"Custers","sequence":"additional","affiliation":[{"name":"Janssen Infectious Diseases and Vaccines, Leiden, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanneke","family":"Schuitemaker","sequence":"additional","affiliation":[{"name":"Janssen Infectious Diseases and Vaccines, Leiden, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeronimo","family":"Cello","sequence":"additional","affiliation":[{"name":"Department of Molecular Genetics and Microbiology, Stony Brook University, Stony Brook, NY 11794-5222, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diana","family":"Edo-Matas","sequence":"additional","affiliation":[{"name":"Janssen Infectious Diseases and Vaccines, Leiden, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"345","reference":[{"key":"vir000197-Beale1","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4419-1339-5_20"},{"key":"vir000197-Belnap1","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1073\/pnas.97.1.73","article-title":"Three-dimensional structure of poliovirus receptor bound to poliovirus","volume":"97","author":"Belnap","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"vir000197-Bodian1","first-page":"234","article-title":"Differentiation of types of poliomyelitis viruses; the grouping of 14 strains into three basic immunological types","volume":"49","author":"Bodian","year":"1949","journal-title":"Am J Hyg"},{"key":"vir000197-Borzakian1","doi-asserted-by":"crossref","first-page":"2914","DOI":"10.1128\/JVI.67.5.2914-2917.1993","article-title":"Precise missense and silent point mutations are fixed in the genomes of poliovirus mutants from persistently infected cells","volume":"67","author":"Borzakian","year":"1993","journal-title":"J Virol"},{"key":"vir000197-Bottiger1","doi-asserted-by":"publisher","DOI":"10.1016\/0264-410X(90)90244-G"},{"key":"vir000197-Bouchard1","doi-asserted-by":"crossref","first-page":"4972","DOI":"10.1128\/JVI.69.8.4972-4978.1995","article-title":"Determinants of attenuation and temperature sensitivity in the type 1 poliovirus Sabin vaccine","volume":"69","author":"Bouchard","year":"1995","journal-title":"J Virol"},{"key":"vir000197-Coid1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(60)90341-X"},{"key":"vir000197-Coid12","doi-asserted-by":"publisher","DOI":"10.1002\/path.1700790214"},{"key":"vir000197-Coid123","first-page":"387","article-title":"The virulence of strains of poliovirus for cynomologus monkeys after subcutaneous injection","volume":"59","author":"Coid","year":"1961","journal-title":"J Hyg (Lond)"},{"key":"vir000197-Day1","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1353\/hah.2009.0015","article-title":"\u2018An American tragedy\u2019. The Cutter incident and its implications for the Salk polio vaccine in New Zealand 1955\u20131960","volume":"11","author":"Day","year":"2009","journal-title":"Health History"},{"key":"vir000197-Enders1","first-page":"467","article-title":"Alteration in pathogenicity for monkeys of Brunhilde strain of poliomyelitis virus following cultivation in human tissues","volume":"11","author":"Enders","year":"1952","journal-title":"Fed Proc"},{"key":"vir000197-Evans1","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1136\/bmj.2.5037.124","article-title":"Safety and antigenic potency testing of poliomyelitis vaccine; a report from the Biological Standards Control Laboratory, Medical Research Council Laboratories, London, N.W.3","volume":"2","author":"Evans","year":"1957","journal-title":"Br Med J"},{"key":"vir000197-Gear1","first-page":"587","article-title":"The South African poliomyelitis vaccine","volume":"30","author":"Gear","year":"1956","journal-title":"S Afr Med J"},{"key":"vir000197-He1","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.77.8.4827-4835.2003"},{"key":"vir000197-Koike1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.88.3.951"},{"key":"vir000197-Macadam1","doi-asserted-by":"publisher","DOI":"10.1006\/viro.1993.1003"},{"key":"vir000197-Martin1","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.76.11.5339-5349.2002"},{"key":"vir000197-Martin12","doi-asserted-by":"publisher","DOI":"10.1099\/vir.0.19088-0"},{"key":"vir000197-Minor1","first-page":"141","article-title":"Antigenic structure of poliovirus","volume":"3","author":"Minor","year":"1986","journal-title":"Microbiol Sci"},{"key":"vir000197-Minor12","doi-asserted-by":"publisher","DOI":"10.1099\/0022-1317-67-7-1283"},{"key":"vir000197-Minor123","doi-asserted-by":"publisher","DOI":"10.1006\/biol.1993.1096"},{"key":"vir000197-Nathanson1","first-page":"61","article-title":"The Cutter incident. Poliomyelitis following formaldehyde-inactivated poliovirus vaccination in the United Sates during the spring of 1955. III. Comparison of clinical character of vaccinated and contact cases occurring after use of high rate lots of Cutter Vaccine","volume":"78","author":"Nathanson","year":"1963","journal-title":"Am J Hyg"},{"key":"vir000197-Nicholson1","doi-asserted-by":"crossref","first-page":"5886","DOI":"10.1128\/JVI.65.11.5886-5894.1991","article-title":"Structural and functional analysis of the ribosome landing pad of poliovirus type 2: in vivo translation studies","volume":"65","author":"Nicholson","year":"1991","journal-title":"J Virol"},{"key":"vir000197-Offit1","first-page":"105","article-title":"What went wrong at Cutter Laboratories","volume-title":"The Cutter Incident: How America's First Polio Vaccine Led to the Growing Vaccine Crisis","author":"Offit","year":"2005"},{"key":"vir000197-Pliaka1","doi-asserted-by":"publisher","DOI":"10.1586\/erv.12.28"},{"key":"vir000197-Reed1","first-page":"493","article-title":"A simple method of estimating fifty per cent endpoint","volume":"27","author":"Reed","year":"1938","journal-title":"Am J Hyg"},{"key":"vir000197-Ren1","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1128\/JVI.65.3.1377-1382.1991","article-title":"Identification of two determinants that attenuate vaccine-related type 2 poliovirus","volume":"65","author":"Ren","year":"1991","journal-title":"J Virol"},{"key":"vir000197-Rieder1","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.74.22.10371-10380.2000"},{"key":"vir000197-Sabin1","doi-asserted-by":"publisher","DOI":"10.1097\/00000441-195507000-00001"},{"key":"vir000197-Sabin12","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1955.tb42565.x"},{"key":"vir000197-Sabin123","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1957.62980110008008"},{"key":"vir000197-Sabin1234","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/0092-1157(73)90048-6","article-title":"History of Sabin attenuated poliovirus oral live vaccine strains","volume":"1","author":"Sabin","year":"1973","journal-title":"J Biol Stand"},{"key":"vir000197-Salk1","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1001\/jama.1953.13.1081","article-title":"Studies in human subjects on active immunization against poliomyelitis. I. A preliminary report of experiments in progress","volume":"151","author":"Salk","year":"1953","journal-title":"J Am Med Assoc"},{"key":"vir000197-Sanders1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2012.10.070"},{"key":"vir000197-Shiroki1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/JVI.71.1.1-8.1997","article-title":"Host range phenotype induced by mutations in the internal ribosomal entry site of poliovirus RNA","volume":"71","author":"Shiroki","year":"1997","journal-title":"J Virol"},{"key":"vir000197-Song1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1211484109"},{"key":"vir000197-SSI1","volume-title":"Description of VeroPol IPV Vaccine SSI","year":"2014"},{"key":"vir000197-van1","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.1073\/pnas.83.8.2330","article-title":"Synthesis of infectious poliovirus RNA by purified T7 RNA polymerase","volume":"83","author":"van der Werf","year":"1986","journal-title":"Proc Natl Acad Sci U S A"},{"key":"vir000197-Verdijk1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2014.07.029"},{"key":"vir000197-Westrop1","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1128\/JVI.63.3.1338-1344.1989","article-title":"Genetic basis of attenuation of the Sabin type 3 oral poliovirus vaccine","volume":"63","author":"Westrop","year":"1989","journal-title":"J Virol"},{"key":"vir000197-WHO1","article-title":"Recommendations for the production and control of poliomyelitis vaccine (inactivated)","volume-title":"Technical Report Series No. 910","year":"2002"},{"key":"vir000197-Zuker1","doi-asserted-by":"crossref","first-page":"3406","DOI":"10.1093\/nar\/gkg595","article-title":"Mfold web server for nucleic acid folding and hybridization prediction","volume":"31","author":"Zuker","year":"2003","journal-title":"Nucleic Acids Res"}],"container-title":["Journal of General Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.microbiologyresearch.org\/content\/journal\/jgv\/10.1099\/vir.0.000197?crawler=true","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,9]],"date-time":"2022-05-09T18:01:23Z","timestamp":1652119283000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.microbiologyresearch.org\/content\/journal\/jgv\/10.1099\/vir.0.000197"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9,1]]},"references-count":42,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2015,9,1]]}},"URL":"https:\/\/doi.org\/10.1099\/vir.0.000197","relation":{},"ISSN":["0022-1317","1465-2099"],"issn-type":[{"value":"0022-1317","type":"print"},{"value":"1465-2099","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9,1]]}}}